Acadia Pharmaceuticals | ACAD - PE Price to Earnings


Acadia Pharmaceuticals reported $13.7 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
ALKERMES USD 14.9 1.11 Sep/2025
Biogen USD 9.38 3.02 Sep/2025
BioMarin Pharmaceutical USD 19.45 4.32 Sep/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Corcept Therapeutics USD 94.18 30.36 Sep/2025
Eisai JPY 26.16 4.7 Sep/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Incyte USD 17.63 2.86 Sep/2025
J&J USD 23.62 0.86 Dec/2025
Moderna USD 27.22 14.51 Jun/2023
Neurocrine Biosciences USD 33.27 9.34 Sep/2025
Pfizer USD 9.3 1.57 Sep/2025
Prothena USD 22.11 11.37 Mar/2022
PTC Therapeutics USD 6.73 0.26 Sep/2025
Sarepta Therapeutics USD 27.27 0 Jun/2025
Vertex Pharmaceuticals USD 23.93 3.88 Sep/2025